Inpatient thromboprophylaxis use in U.S. hospitals: Adherence to the seventh American College of Chest Physician's recommendations for at‐risk medical and surgical patients

Journal of Hospital Medicine - Tập 4 Số 8 - 2009
Alpesh Amin1, Stephen Stemkowski2, Jay Lin3, Guiping Yang2
1University of California–Irvine, 101 The City Drive South, Building 58, Room 110, ZC‐4076H, Orange, CA 92868
2S. Stemkowski and G Yang: Premier Research Service, Premier, Inc., Charlotte, North Carolina
3J Lin: Health Outcomes sanofi‐aventis, Bridgewater, New Jersey

Tóm tắt

AbstractBACKGROUND:The clinical venous thromboembolism (VTE) burden remains high in the United States, despite guidelines recommending that safe and effective VTE prophylaxis be available. This study assesses the real‐world rate of appropriate inpatient VTE prophylaxis in hospitalized U.S. medical and surgical patients at risk of VTE, in accordance with the seventh American College of Chest Physicians, (ACCP) guidelines.METHODS:Medical and surgical discharges from Premier's Perspective™ database between January 1, 2005 and December 31, 2006 were considered. Discharges aged ≥40 years, with a length of stay ≥6 days, at risk of VTE due to the presence of ≥1 VTE risk factors identified by the seventh ACCP guidelines, and without contraindications for anticoagulation, were included in the analysis. Appropriate prophylaxis was determined by comparing the daily use, dosage, and duration of anticoagulants and compression devices with the seventh ACCP recommendations for each medical condition or surgical procedure.RESULTS:A total of 390,024 discharges met the inclusion criteria, of which 201,224 (51.6%) were medical discharges and 188,800 (48.4%) were surgical discharges. Overall, 65.9% of medical discharges and 77.7% of surgical discharges received at least 1 order for VTE prophylaxis during hospitalization. However, only 12.7% of medical discharges and 16.4% of surgical discharges received appropriate prophylaxis when the recommended prophylaxis type, dose, and duration from the seventh ACCP guidelines were taken into account.CONCLUSIONS:Few medical and surgical patients at high risk of VTE receive appropriate inpatient prophylaxis in accordance with guideline recommendations. It is important for individual hospitals to improve VTE prophylaxis practices to meet national performance initiatives. Journal of Hospital Medicine 2009;4:E15–E21. © 2009 Society of Hospital Medicine.

Từ khóa


Tài liệu tham khảo

10.1378/chest.126.3_suppl.338S

Heit JA, 2005, Estimated annual number of incident and recurrent, non‐fatal and fatal venous thromboembolism events in the US, Blood, 106, 910, 10.1182/blood.V106.11.910.910

10.1056/NEJM199909093411103

10.1002/bjs.1800840817

10.1378/chest.120.6.1964

Cardiovascular Disease Educational and Research Trust, 2006, Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines According to Scientific Evidence), Int Angiol, 25, 101

Chyna JT, 2005, Preparing for DVT core measures. Healthcare leaders should begin preparing for new deep vein thrombosis prevention standards, Healthc Exec, 20, 66

Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Available at:http://www.jointcommission.org. Accessed May 2009.

U.S. Surgeon General. Summary and consideration of priority areas for action: Surgeon General's workshop on deep‐vein thrombosis. Available at:http://www.surgeongeneral.gov/topics/deepvein/workshop/presentations/summary.pdf. Accessed May 2009.

Medicare Quality Improvement Committee. SCIP Project Information. Available at:http://www.qualitynet.org/dcs/ContentServer?c=MQParents &pagename=Medqic%2FContent%2FParentShellTemplate&cid=11229049 30422&parentName=TopicAccessed October 2006.

10.1378/chest.119.1_suppl.132S

10.1186/1477-9560-2-3

10.1046/j.1525-1497.2002.10903.x

10.1016/j.amjcard.2003.09.057

10.1001/archinte.165.13.1458

10.1111/j.1538-7836.2007.02650.x

Amin A, 2008, Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis?, Thromb Haemost, 99, 796, 10.1160/TH07-11-0708

U.S. Department of Health and Human Services. Policy for Protection of Human Research Subjects. Available at:http://www.hhs. gov/ohrp/humansubjects/guidance/45cfr46.htm#46.101. Accessed: May 2009.

10.1016/S0149-2918(04)90038-0

1986, ACCP/NHLBI National Conference on Antithrombotic Therapy, Chest, 89, 1S

10.1378/chest.08-0656

10.1002/ajh.20983

10.1056/NEJMoa041533

Thông tin
Thông tin xuất bản

Journal of Hospital Medicine

Tập 4 Số 8

Thông tin tác giả